Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Oncogenesis
SJR: 0.946 SNIP: 0.503 CiteScore™: 2

ISSN Imprimer: 0893-9675
ISSN En ligne: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v13.i1.10
pages 1-38

Molecular Mechanisms of Apoptosis in Prostate Cancer

Petra I. Lorenzo
Department of Molecular Biosciences, University of Oslo, Postboks 1041, Blindern, 0316 Oslo, Norway
Yke J. Arnoldussen
Department of Molecular Biosciences, University of Oslo, Postboks 1041, Blindern, 0316 Oslo, Norway
Fahri Saatcioglu
Department of Molecular Biosciences, University of Oslo, Postboks 1041, Blindern, 0316 Oslo, Norway

RÉSUMÉ

Prostate cancer is the most frequently diagnosed noncutaneous cancer in men in Western countries. As in the normal prostate, the initial stages of prostate cancer progression depend on androgens that increase proliferation and inhibit apoptosis. Androgen-deprivation therapy is the major course of treatment in recurrent and metastatic prostate cancer. However, in most cases prostate cancer progresses to an apoptosis-resistant androgen-independent stage for which there is no available therapy. It is therefore important to understand the molecular mechanisms underlying prostate cancer progression, and how prostate cancer cells evade apoptotic mechanisms that give rise to their uncontrolled growth behavior. Here, we have reviewed the most important signaling pathways implicated in prostate cancer apoptosis and cell growth and how they may be deregulated during prostate cancer progression.


Articles with similar content:

Molecular Cytogenetics of Prostate Cancer
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 3-4
Pasi A. Koivisto
Increased Expression of COX-2 in the Development of Human Lung Cancers
Journal of Environmental Pathology, Toxicology and Oncology, Vol.21, 2002, issue 2
Ken-ichi Kozaki, Hiroyuki Achiwa, Toyoaki Hida, Takashi Takahashi, Yasushi Yatabe
On the Mechanism of Cellular Toxicity in Breast Cancer by Ionizing Radiation and Chemotherapeutic Drugs
Journal of Environmental Pathology, Toxicology and Oncology, Vol.33, 2014, issue 1
Vidhula Ahire, Kaushala Prasad Mishra, G. R. Kulkarni
MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 2
Faezeh Ghasemi, Atefeh Amiri, Hamed Mirzaei, Aria Masoudifar, Reza Salarinia, Arad Mobasher Aghdam
Engaging Cell Death Pathways for the Treatment of Rhabdomyosarcoma
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Stephanie Langlois, Kyle N. Cowan, David Grynspan, Martin Holcik, Christine C. Dobson